Strategic Investment

We belong to a new breed of biotech investor that strongly believes in the concept of "smart money". We combine our capital with our collaborative drug development team to deliver a unique investment formulation.

KreaMedica invests in fast-growing biotechnology companies that develop innovative drugs or disruptive technologies. We focus on biotech companies whose products address areas of significant unmet medical needs and thus have above-average sales and profit growth potential. Furthermore, we focus on the earlier phases of development where most of the funding challenges exist. We believe that providing the capital and expertise at this crucial moment is key to allowing new inventions and technologies to show their true potential.


ATRIVA Therapeutics


Medraxa Therapeutics

Cetya Therapeutics



Avalyn Pharma

MHB Labs





"An economist is an expert who will know tomorrow why the things he predicted yesterday didn't happen today."

Laurence J. Peter